DIA
VYNT

Denver Investment Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Denver Investment Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-85
Closed -$42K – 526
2015
Q4 		$42K Sell
85
-9
-10% -$6.5K ﹤0.01% 499
2015
Q3 		$111K Buy
+94
New +$144K ﹤0.01% 500

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Denver Investment Advisors's VYNT Position: Q1 2016 in Review

Denver Investment Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2016, closing a stake of 85 shares — an estimated $42K sold.

Denver Investment Advisors first reported a position in VYNT in Q3 2015 and held it in 2 quarters. The position peaked at $111K in Q3 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2016.

  • Denver Investment Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 85 Vyant Bio, Inc. Common Stock shares in Q1 2016, an estimated $42K.
  • Denver Investment Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Denver Investment Advisors's Vyant Bio, Inc. Common Stock position peaked at $111K in Q3 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.